Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
53M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
4.67M
-
Shares change
-
+3.78M
-
Total reported value, excl. options
-
$827K
-
Value change
-
+$650K
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$0.18
Significant Holders of Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) as of Q4 2024
34 filings reported holding MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value as of Q4 2024.
Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.67M shares
of 53M outstanding shares and own 8.82% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (3.61M shares), GEODE CAPITAL MANAGEMENT, LLC (284K shares), HB Wealth Management, LLC (107K shares), UBS Group AG (101K shares), RENAISSANCE TECHNOLOGIES LLC (87.5K shares), BlackRock, Inc. (83.3K shares), VANGUARD GROUP INC (75.4K shares), HRT FINANCIAL LP (54.9K shares), TWO SIGMA INVESTMENTS, LP (40.7K shares), and TWO SIGMA SECURITIES, LLC (36.2K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.